For research use only. Not for therapeutic Use.
MMV676584 has anti-tuberculosis avtivity. MMV676584 is a novel agent candidate for eumycetoma[1].
| Catalog Number | I041724 |
| CAS Number | 750621-19-3 |
| Synonyms | 3-chloro-N-(4,5-dihydro-1,3-thiazol-2-yl)-6-fluoro-1-benzothiophene-2-carboxamide |
| Molecular Formula | C12H8ClFN2OS2 |
| Purity | ≥95% |
| InChI | InChI=1S/C12H8ClFN2OS2/c13-9-7-2-1-6(14)5-8(7)19-10(9)11(17)16-12-15-3-4-18-12/h1-2,5H,3-4H2,(H,15,16,17) |
| InChIKey | WIYIHXHWMONCNB-UHFFFAOYSA-N |
| SMILES | C1CSC(=N1)NC(=O)C2=C(C3=C(S2)C=C(C=C3)F)Cl |
| Reference | [1]. Wilson Lim, et al. Addressing the most neglected diseases through an open research model: The discovery of fenarimols as novel drug candidates for eumycetoma. PLoS Negl Trop Dis. 2018 Apr 26;12(4):e0006437. [2]. Clinton G L Veale, et al. Unpacking the Pathogen Box-An Open Source Tool for Fighting Neglected Tropical Disease. ChemMedChem. 2019 Feb 19;14(4):386-453. |
